22 devices · GMDN 62841
This category includes antibodies designed to detect carbonic anhydrase in patient samples. These immunoglobulins bind specifically to carbonic anhydrase antigens and are used in laboratory tests to measure the presence or amount of this enzyme, which can be associated with certain cancers and other medical conditions.
Devices in this category are in vitro diagnostic tools that rely on antibody-antigen interactions for detection. They are intended for use in clinical laboratories to support diagnosis or monitoring, and their regulation depends on the specific test system and intended use as defined by regulatory authorities.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.